COMPASS Pathways director granted 21,110 share options
COMPASS Pathways plc director David Y. Norton received a grant of share options giving him the right to buy 21,110 Ordinary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
COMPASS Pathways plc director David Y. Norton received a grant of share options giving him the right to buy 21,110 Ordinary Shares. The options have an exercise price of $11.85 per share and expire on 26 May 2036. The underlying shares vest in full on the earlier of the first anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders. The Ordinary Shares may be represented by American Depositary Shares on a 1:1 basis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 21,110 | $0.00 | $0.00 |
Footnotes (2)
- F1. The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.
- F2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Key Figures
Key Terms
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did COMPASS Pathways (CMPS) report for David Y. Norton?
What is the exercise price and expiry of David Y. Norton’s COMPASS Pathways options?
Is David Y. Norton’s Form 4 transaction a market purchase or sale of COMPASS Pathways stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.